Raymond James & Associates’s Omeros OMER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-34,600
Closed -$17.3K 4016
2022
Q4
$17.3K Buy
+34,600
New +$95.4K ﹤0.01% 3808
2022
Q3
Sell
-42,500
Closed -$9K 4083
2022
Q2
$9K Sell
42,500
-4,600
-10% -$15.6K ﹤0.01% 3944
2022
Q1
$11K Buy
+47,100
New +$294K ﹤0.01% 4057
2021
Q4
Sell
-53,600
Closed -$34K 4243
2021
Q3
$34K Buy
+53,600
New +$802K ﹤0.01% 3951
2021
Q2
Sell
-50,600
Closed -$152K 4163
2021
Q1
$152K Buy
+50,600
New +$984K ﹤0.01% 3689
2020
Q4
Sell
-26,600
Closed -$13K 3844
2020
Q3
$13K Sell
26,600
-1,900
-7% -$24.5K ﹤0.01% 3532
2020
Q2
$78K Sell
28,500
-71,900
-72% -$1.07M ﹤0.01% 3327
2020
Q1
$52K Buy
+100,400
New +$1.34M ﹤0.01% 3311
2019
Q4
Sell
-51,400
Closed -$31K 3726
2019
Q3
$31K Buy
+51,400
New +$882K ﹤0.01% 3511
2019
Q2
Sell
-22,100
Closed -$10K 3719
2019
Q1
$10K Buy
+22,100
New +$319K ﹤0.01% 3569
2018
Q4
Sell
-46,900
Closed -$147K 3651
2018
Q3
$147K Buy
46,900
+17,600
+60% +$392K ﹤0.01% 3368
2018
Q2
$35K Buy
29,300
+18,100
+162% +$314K ﹤0.01% 3462
2018
Q1
$7K Buy
+11,200
New +$157K ﹤0.01% 3418
2017
Q4
Sell
-13,000
Closed -$6K 3499
2017
Q3
$6K Sell
13,000
-32,300
-71% -$684K ﹤0.01% 3372
2017
Q2
$103K Buy
45,300
+31,400
+226% +$548K ﹤0.01% 3111
2017
Q1
$22K Sell
13,900
-5,900
-30% -$64.5K ﹤0.01% 3205
2016
Q4
$4K Sell
19,800
-33,300
-63% -$340K ﹤0.01% 3213
2016
Q3
$22K Buy
53,100
+43,000
+426% +$491K ﹤0.01% 3132
2016
Q2
$3K Sell
10,100
-55,800
-85% -$687K ﹤0.01% 2999
2016
Q1
$83K Buy
+65,900
New +$801K ﹤0.01% 2744

Other funds holding OMER

Raymond James & Associates's OMER Position: Q1 2024 in Review

Raymond James & Associates sold out of Omeros (OMER) in Q1 2024, closing a stake of 10,925 shares — an estimated $35.7K sold.

Raymond James & Associates first reported a position in OMER in Q4 2013 and held it in 41 quarters. The position peaked at $2.1M in Q4 2014. 99 funds tracked by Wall St. Rank hold OMER as of Q1 2024.

  • Raymond James & Associates reported no remaining Omeros position as of Q1 2024 after selling out during the quarter.
  • Raymond James & Associates sold 10,925 Omeros shares in Q1 2024, an estimated $35.7K.
  • Raymond James & Associates first reported a position in Omeros in Q4 2013 and held it in 41 quarters.
  • Raymond James & Associates's Omeros position peaked at $2.1M in Q4 2014.
  • 99 funds tracked by Wall St. Rank held Omeros as of Q1 2024.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.